That's essential, due to the fact that the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be effective. In other words, we need to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error procedure (democratic republic). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was a breakthrough nearly no one noticed. But it's going to have extensive implications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of financial investment chances in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back maybe considerably prior to going higher - biotech stocks. I have actually been covering bitcoin for a very long time now. Among the first research reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mainly educating readers. However that's not the big question anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge factor I'm bullish on it this year. jeff brown. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many great personal companies on the edge of striking the public markets And I've been working on a brand-new way for you to invest even prior to these business go public.
This opportunity has been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to book your area free of charge.
Emma Walsh here, managing editor of the Diary. Regular Journal readers know that tech isn't our normal beat (jeff brown stock predictions 2021). And when it concerns tech investing, we leave it to the experts. Fortunately, we have several such experts in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (jeff brown genome sequencing). In truth, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big image and predict what's simply around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and far more. These patterns are experiencing rapid development and creating incredible opportunities for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. the legacy report prediction. But regardless of what numerous readers may think, this is a pattern that's simply getting going. Even though the COVID-19 pandemic interfered with supply chains in 2015, an impressive 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (united arab emirates). Losing two months of manufacturing and sales really impacts the number of 5G gadgets are offered in the calendar year. When you consider all of that, selling 250 million systems is exceptional. More notably, the delays triggered by the pandemic created a load of suppressed need. Which demand is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be delivered in 2021 - artificial intelligence. Which's not my only 5G prediction When I have actually discussed 5G in the past, I've described its 3 different phases.
In Stage 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase 3, 5G services start to be provided (social media). That's when we begin to see applications running on 5G networks. Believe of things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Stage Three by this summertime. This begins something of a virtuous cycle: The majority of people do not actually appreciate the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open up a suite of unbelievable applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment chances going forward will be enormous. Stepping away from 5G, the next crucial technology I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not function properly. CRISPR utilizes a comparable idea but with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And throughout that time, there were really only 3 business running in this area. But things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're treating diseases and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR business is going public and providing incredible returns. This entire industry is successfully a greenfield chance.
There's room for many companies to exist in this space. jeff brown genetic sequencer stock. And there will be more. That's my prediction for CRISPR in 2021. I anticipate that two or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things happening at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software application can precisely anticipate the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is essential because the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental process. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug treatments produced using this innovation. This was among those developments that practically nobody noticed. But it's going to have profound ramifications for treating illness. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back maybe significantly before going greater. I've been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin - second wave. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for any person who followed my suggestion. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. last week. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information is up to date since February 2021, however we might not independently validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like capability to pick winning innovation stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience gives him an exceptional viewpoint on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares much of his best picks in the Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an exceptional reputation as a stock-picker, and he successfully anticipated a few of the biggest economic occasions of the past twenty years. Although he doesn't appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it best whenever, however Jeff Brown's accurate predictions have made him legions of devoted followers. That says a lot about his capability. The Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research study uses several research study services with a wide array of specializations - tech stock.
The company is also affiliated with Bonner & Partners, another well-respected research publisher - jeff brown 2021 stock predictions. On its website, Brownstone says its objective is to offer retail investors with professional-grade research study: "For too long, the very best financial investment research study has actually not been available to private financiers. It has been generally booked for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown biotech pick. The mission of Brownstone Research is to make that type of exclusive research study offered to any financiers wanting to get an edge in the markets. The objective is basic to provide unique and rewarding financial investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the firm's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After decades of steady success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you know even a bit about the market, you understand that he has a track record as a King Midas of sorts. jeff brown top biotech 2020. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown believes S.A.V. black sea. could be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two cutting-edge innovations: synthetic intelligence and electric automobiles. Musk hopes the combination will assist him develop the first fully-autonomous, self-driving cars ever. It's absolutely nothing brief of the vehicle industry's Holy Grail. As you know, electric automobiles and self-driving automobile stocks have actually been big this year, but the Wall Street machine has approved hype without much tangible result. In spite of a drastic increase in competition over the previous couple of years, Brown still believes Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties it all together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transport. Basically, this technology would permit you to rent your vehicle as a self-governing, self-driving taxi when you're not utilizing it. You simply get out of the automobile and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a hefty chunk of the profits. It sounds insane, but it might be closed than you think.